PubAg

Main content area

The mucosal adjuvant effect of plant polysaccharides for induction of protective immunity against Helicobacter pylori infection

Author:
Liu, Chang, Luo, Jiao, Xue, Ruo-Yi, Guo, Ling, Nie, Li, Li, Sun, Ji, Lu, Ma, Cong-Jia, Chen, Da-Qun, Miao, Kuan, Zou, Quan-Ming, Li, Hai-Bo
Source:
Vaccine 2019 v.37 no.8 pp. 1053-1061
ISSN:
0264-410X
Subject:
Astragalus, Epimedium, Helicobacter pylori, Polygonatum, Toll-like receptor 2, Trollius chinensis, absorption, adjuvants, antigens, blood serum, immune response, immunoglobulin A, immunoglobulin G, intestines, mice, mucosa, ovalbumin, polysaccharides, protective effect, rhizomes, saliva, urease, vaccination, vaccines
Abstract:
Some plant polysaccharides (PPSs) had been used as the adjuvants for systemic vaccination. In this study, we investigated whether PPSs could exhibit adjuvant effect at the mucosa. Groups of mice were intranasally immunized with Epimedium Polysaccharide (EPS), Trollius chinensis polysaccharide (TCPS), Siberian solomonseal rhizome polysaccharide (SSRPS) and Astragalus polysaccharides (APS) together with ovalbumin (OVA). Significantly higher levels of OVA-specific IgG in serum and secretory IgA in saliva, vaginal wash and intestinal lavage fluid were induced after immunization with OVA plus one of the four PPSs compared to OVA alone. Antigen absorption and TLR2 (Toll-like receptor 2) activation may be related to their mucosal adjuvant effect. Of note, when APS used as an adjuvant, intranasally vaccination with recombination UreB (rUreB, Urease subunit B) conferred more robust protection against Helicobacter pylori (H. pylori). Immunized with rUreB in combination APS resulted in mixed specific Th1 and Th17 immune response, which may contribute to the inhibition of H. pylori colonization. Though specific Th2-dominant responses were elicited when the other three PPS intranasally immunized with rUreB, no significant difference in the protective effect were found between those groups and rUreb alone group. Taken together, the four PPSs may be promising candidates for mucosal adjuvant, and APS could enhance rUreB-specific protective immunity against H. pylori infection.
Agid:
6295441